UC WAR. CALL 06/24 ECV/ DE000HC46H99 /
2024-05-15 11:47:10 AM | Chg.+0.0330 | Bid1:02:24 PM | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.0970EUR | +51.56% | 0.0980 Bid Size: 10,000 |
- Ask Size: - |
ENCAVIS AG INH. O.N... | 18.00 EUR | 2024-06-19 | Call |
GlobeNewswire
1:15 PM
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at ...
GlobeNewswire
1:03 PM
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire
1:01 PM
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presente...
GlobeNewswire
1:00 PM
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GlobeNewswire
1:00 PM
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
GlobeNewswire
1:00 PM
Dorman Products expands its catalog of cost-saving and aftermarket-exclusive repair solutions
GlobeNewswire
1:00 PM
Plug to Revolutionize Middle-Mile Delivery with Class 6 Fuel Cell Electric Truck Integration
GlobeNewswire
1:00 PM
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
1:00 PM
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
1:00 PM
Boralex announces a substantial 62% increase in net earnings and continued disciplined development o...
GlobeNewswire
1:00 PM
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
1:00 PM
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the ...